• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Teladoc Brings At-Home Diabetes Testing for Members

by Fred Pennic 08/10/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
UCSF Launches SUGAR Clinical Trial Study to Compare Livongo’s Diabetes Management Program to Standard Diabetes Care

What You Should Know:

– Teladoc Health recently added an at-home A1C testing program to its chronic care solution, making it easier for members to manage their diabetes while also bridging health equity gaps in chronic condition care.

– Livongo by Teladoc Health members will have the option to receive at-home A1C tests provided by LetsGetChecked, a leading healthcare solutions company that enables providers to administer diagnostics and care directly into the homes of patients. The announcement comes as new company data shows that 58% of members opt for the at-home service when given the chance, with a three to four times greater consumer test return rate than other options on the market.  

At-Home Testing Improves Diabetes Care & Control for Individuals, Providers & Payers Alike

Livongo by Teladoc Health members receive the at-home A1C tests – also known as the hemoglobin A1C or HbA1c test – with one-click on their blood glucose meters. A1C is one of the commonly used tests to diagnose pre-diabetes and diabetes, and the main test to help members and their care teams manage diabetes. Individuals self-administer the sample blood collection via finger prick, and based on their results, are offered personalized next steps aimed to help members lower their A1C. 

Coupled with the highly successful Livongo by Teladoc Health diabetes management program and whole-person integrated programs to address hypertension, weight, mental health and other frequent comorbidities, 87% of members using the in-home test reported a controlled A1C of 8% or less. For context, the commercial health plan average was 54%[1] of members having a controlled A1C of 8% or less, reinforcing the positive impact of the Teladoc Health program. 

“At-home testing will not only help members better understand their risk, but better manage their conditions and live their healthiest lives on their own terms,” said Kelly Bliss, U.S. Group Health President at Teladoc Health. “For the more than 37 million people in the United States living with diabetes, this is a quick and effortless way for us to engage with members, at the moment they are managing their diabetes.”  

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: blood collection, Care Coordination, care teams, chronic care, diabetes, Diabetes Management, Health Equity, Hypertension, LetsGetChecked, Livongo, Mental Health, Payers, risk, Teladoc

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |